Variant Bio is a startup based in Germany, most recent round Series B, 2 tracked investors.
Variant Bio is a company founded in 2017 headquartered in Germany. Its most recent tracked round is Series B. Brouky records 2 investors associated with the company.
Variant Bio leverages human genetic diversity to identify novel therapeutic targets, focusing on individuals with exceptional health-related traits to transform drug development.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.